<--- Back to Details
First PageDocument Content
Biotechnology / Fanconi anemia / FANCG / FANCA / Myelodysplastic syndrome / Bone marrow failure / Aplastic anemia / Gene therapy / Hematopoietic stem cell transplantation / Medicine / Biology / Hematology
Date: 2014-06-02 11:44:46
Biotechnology
Fanconi anemia
FANCG
FANCA
Myelodysplastic syndrome
Bone marrow failure
Aplastic anemia
Gene therapy
Hematopoietic stem cell transplantation
Medicine
Biology
Hematology

FAMILY NEWSLETTER #25 A Semi-annual Newsletter on Fanconi Anemia for Families, Physicians and Research Scientists

Add to Reading List

Source URL: www.fanconi.org

Download Document from Source Website

File Size: 995,79 KB

Share Document on Facebook

Similar Documents

Biotechnology, BS

Biotechnology, BS "DBEFNJD.BQ  5IF"DBEFNJD.BQTFSWFTBTBTVHHFTUFEDPVSTFTFRVFODFPOMZ4UVEFOUTBSFOPUMJNJUFEUPUIJTQMBOJUJTNFBOUUPCFVTFEBT

DocID: 1xTqy - View Document

PDF Document

DocID: 1wroO - View Document

Building A Better Mousetrap:  Patenting Biotechnology In The European Community

Building A Better Mousetrap: Patenting Biotechnology In The European Community

DocID: 1vr7C - View Document

BIOTECH & PHARMA IN FRANCE KEY FACTS & FIGURES ¾¾ The French biotechnology sector ranks number 3 in Europe with more than 400 companies behind the UK and Germany ¾¾ First producer of medicines in Europe with 220 prod

BIOTECH & PHARMA IN FRANCE KEY FACTS & FIGURES ¾¾ The French biotechnology sector ranks number 3 in Europe with more than 400 companies behind the UK and Germany ¾¾ First producer of medicines in Europe with 220 prod

DocID: 1vq6b - View Document

Biotechnology Consultation Agency Response Letter BNF

Biotechnology Consultation Agency Response Letter BNF

DocID: 1vpUZ - View Document